Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208935 · ClinicalTrials.gov registry record · Phase 2
Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 157
- Enrollment target
NCT01208935 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 157 participants.
The verdict
NCT01208935, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 157 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety, tolerability, compliance and efficacy of two different forms of nicotine replacement therapy (NRT) (the nicotine transdermal patch and the nicotine gum) in a nicotine-dependent adolescent population.
Interventions
- DRUG Nicotine Patch
- DRUG Nicotine Gum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 1999-08 |
| Est. Completion | 2004-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01208935
The ClinicalTrials.gov registry entry for NCT01208935 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine Patch is the first listed.
NCT01208935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01208935 about?
NCT01208935 is a clinical study titled "Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence". The purpose of this study is to test the safety, tolerability, compliance and efficacy of two different forms of nicotine replacement therapy (NRT) (the nicotine transdermal patch and the nicotine gum) in a nicotine-dependent adolescent population.
What is the current status of trial NCT01208935?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 157 participants. The study started on 1999-08. Estimated completion is 2004-08.
What interventions are being tested in trial NCT01208935?
The interventions under investigation include: Nicotine Patch (DRUG), Nicotine Gum (DRUG).
Who is sponsoring clinical trial NCT01208935?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.